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Transcriptiona b s t r a c t
Transcription factor Snail mediates epithelial to mesenchymal transitions (EMT) by coordinate
repression of epithelial markers, facilitating mass cell movement during germ layer formation.
Aberrant reprogramming in its signaling pathways causes metastatic cancer. Snail’s involvement
in ‘‘fate-changing’’ decisions is however not understood. Cripto-1 shares a common temporal
expression pattern with Snail during development. While Cripto-1 is required for mammary
morphogenesis and hematopoietic stem cell renewal, its unregulated expression causes metastatic
cancers. Therefore, we suspected that Snail regulates the expression of Cripto-1 controlling deci-
sions such as motility, transformation and differentiation. We demonstrate that Snail represses
Cripto-1 gene by direct transcriptional interaction and propose a novel mechanism by which it
co-ordinately regulates cell fate decisions during development and could be causal of cancers.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cripto-1/teratoma derived growth factor-1 (TDGF-1) is a mem-
brane anchored/secretory protein that functions as a co-receptor
for the TGF-beta ligands, Activin and Nodal [1]. Although it is
expressed at various stages of embryonic development including
gastrulation, its molecular role in cellular physiology remains
unclear (e.g., in facilitating the speciﬁcation of the anterior–poster-
ior axis) [2–4]. In adults, its tissue restricted expression occurs to
support hematopoietic stem cell renewal in the bone marrow
and for mammary gland morphogenesis [5–7]. In addition to the
early identiﬁcation of Cripto-1 as a cofactor in the TGF-beta path-
way, it is now reported to be involved in the Wnt/Beta-catenin,
Notch and Akt pathways [8–11].
Involvement of Cripto-1 in myriad pathways controlling growth
and differentiation has led to its identiﬁcation as an oncogene and
a biomarker of several cancers including metastatic breast cancer
and neuroblastomas [10–12]. Some of the mechanisms by which
Cripto-1 directly increases cell proliferation are (i) enhanced ligand
binding activities for growth differentiating factors, GDF1 and
GDF3 in the TGF-beta pathway, (ii) activation of MAPK/c-src/
PI3k/protein kinase B, and (iii) activation of the EGF-receptor[10]. Concomitantly, inhibition of Cripto-1 activity either by tumor
suppressors like caveolin-1 or through antibody-mediated-
depletion, reduces cell proliferation [13,14].
Snail is a zinc ﬁnger, helix-loop-helix containing transcription
factor involved in speciﬁcation of the mesodermal cell lineage by
orchestrating favorable molecular programs like repression of
epithelial markers, changes in the cell cycle, increased survival,
among others [15–18]. Absence of Snail leads to the loss of left–
right axis asymmetry in mice, either independently or as a result
of the pro-mesenchymal properties of Snail activation [19].
Cancers, in which Snail is atypically expressed are often associated
with increased metastasis, in part due to increased motility con-
ferred by Snail-mediated repression of E-cadherin [4,20]. Further,
Snail is also known to arrest cell cycle while inducing motility
and enhancing cell survival [17,21].
Based on the involvement of Snail and Cripto-1 in embryonic
development, promoting motility of cancer cells and seemingly
antagonistic roles of these proteins in cell-cycle progression and
differentiation, we hypothesize that Snail (being a transcription
factor) might affect/regulate Cripto-1 expression. Our in vitro and
in vivo data on binding analysis demonstrates that Snail directly
binds to the E-Box element on the ‘Cripto-1 promoter’ and
represses its expression, also correlating with changes to the
EMT and the cell-cycle. Together, our data elucidate an important
molecular interaction, physiologically designed for cell fate spec-
iﬁcation but aberrantly utilized by cancer for successful metastasis
and growth.
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2.1. Culture of mammalian cell lines
HEK293, IMR-32 and MCF 7 were maintained in DMEM with
high glucose (Gibco-USA), supplemented with 1X antibiotic
(Gibco-USA), 10% FBS at 37 C and 5% CO2.
2.2. Plasmid constructs
pGL4.20 plasmid and pGL4.20 plasmid containing Cripto-1 pro-
moter were kind gift from Dr. Salomon (National Cancer Institute,
USA) [22]. pCDNA3-Flag Snail was a kind gift from Dr. Weiss
(University of Michigan, USA) [23], pEF Cripto-1 was a kind gift
from Dr. Bianco C (National Cancer Institute, USA) [24]. Snail
shRNA (Sc-38398) and control shRNA (Sc-108060) plasmids were
purchased from Santa Cruz Biotechnology, b-gal plasmid was a
kind gift from Dr. Mahapatra (IITM, India) [25].
2.3. Promoter activity analysis by reporter gene (luciferase) assays
HEK293 cells were seeded at 40–50% conﬂuency in 12 well
plate on day 1 and 24 h later cells were transfected with
pGL4.20, pGL4.20-Cripto-1 promoter (200 ng per well) and varying
concentrations of pCDNA3-Flag Snail by calcium phosphate
method. 24 h post transfection, cells were washed with ice cold
PBS and lysed in 200 ll of lysis buffer consisting of 0.1 M phos-
phate buffer (pH 7.4), 0.1% Triton X-100 and 1 mM DTT. 50 ll
lysate was used for luciferase assay with 1 mM luciferin sodium
salt (Sigma Aldrich), 3 mM ATP (Sigma Aldrich), 15 mM MgSO4
and 30 mM HEPES (pH 7.8). Luciferase readings were normalized
against transfection control by b-galactosidase assay.
2.4. Analysis of protein expression
Transfected cells were lysed in ‘RIPA’ buffer, supplemented with
1X protease and phosphatase inhibitor. Total protein concentration
was estimated by BCA method (PI-23221, Thermo scientiﬁc, USA).
50 lg of protein was loaded on SDS PAGE, transferred onto nitro-
cellulose membrane and blocking was carried out for 20 min at
room temperature with 5% skimmed milk in TBST. Membrane
was probed with primary antibody at 4 C over night, washed three
times with TBST and probed with secondary antibody at room tem-
perature for 1 h and blots were developed with luminol (Sigma #
8511) using Versadoc. Primary antibodies used in this study are
b-Actin (Santa Cruz Biotechnologies # sc-47778), Snail (Santa
Cruz Biotechnologies # sc-10432), E-Cadherin (BD Bioscience #
610181), Vimentin (Santa Cruz Biotechnologies # sc-373717),
p21 (AB biotech # 251259), Cyclin D1 (BD Biosciences #
556470), V5 antibody (Invitrogen # R-960-25). Anti mouse and
anti rabbit secondary antibodies are purchased from Santa Cruze
Biotechnologies (# sc-358914and # sc-2357).
2.5. Gene-expression analysis by qPCR
MCF7 and IMR-32 cells were seeded at a conﬂuency of 30–40%
on day 1 and cells were transfected on day 2 with Snail. Snail sh-
RNAs treated cells were lysed in Trizol, 24 h after transfection
(#10296010, Life technologies, USA) and total RNA was isolated.
1 lg of total RNA was converted into cDNA using ‘transcriptor high
ﬁdelity cDNA synthesis kit’ (05091284001 Roche, Germany).
Relative mRNA levels were analyzed by qPCR with Syber-green
master mix (DyNAmo color Flash SYBR Green qPCR Kit #F-416L,
Thermo scientiﬁc, USA) using Human Cripto-1 (F: 50-
CACGATGTGCGCAAAGAGAA-30; R: 50-TGACCGTGCCAGCATTTACA-30), Snail (F: 50 ACCACTATGCCGCGCTCTT 30; R: 50 GGTCGTAGGGC
TGCTGGAA 30) and Actin (F: 50 TCATGAAGATCCTCACCGAG 30; R:
50 TTGCCAATGGTGATGACCTG 30) speciﬁc primers.
2.6. Electrophoretic mobility shift assay (EMSA)
In order to identify the in vitro interaction of Cripto-1 promoter
with Snail, a 33 bp oligo nucleotide corresponding to Cripto-1 pro-
moter region (Wild type F: 50-GGTGGGCGTCCCGCCCACCTGA-AA
GGTCTCCCC-30, R: 50-GGGGAGACCTTTCAGGTGGGCGGGACGC
CCACC-30 and Snail binding site mutant oligos: 50-GGTGGG
CGTCCCGCCCCCGCGA AAGGTCTCCCC-30, R: 50-GGGGAGACCT
TTCGCGGGGGCGGGACGCCCACC-30), with the Snail binding site in
the center. We followed the protocol of incubating constant
amount of oligos (a ﬁnal concentration of 50 pM) with varying con-
centrations of nuclear protein extract (NPE) (2 and 4 lg).
Binding reactions were performed in a total volume of 20 ll
consisting of 50 pM oligonucleotides, 20 mM HEPES (pH 7.4),
80 mM NaCl, 20 mM KCl, 0.2 ll of 100X protease inhibitor cocktail
and 1-4 lg of total nuclear protein extract (NPE). The mixture was
incubated for 60 min at room temperature and complexes were
resolved by non-denaturing PAGE in 0.5X TBE (45 mM Tris base,
45 mM boric acid, 1 mM EDTA). For super shift experiments, addi-
tional 1-2 lg of Snail antibody (# ab85931, Abcam, UK) was added
and incubated for 4 h at 4 C before the addition of oligonu-
cleotides. Gels were soaked in TBE supplemented with 10 lM
ethidium bromide and incubated for 20–30 min prior to
visualization.
2.7. Chromatin immuno-precipitation assay (ChIP)
Chromatin of 100% conﬂuent IMR-32 cells was cross linked with
proteins in 1% formaldehyde. Nuclear content was extracted and
chromatin was fragmented to a size of 400 bp by sonication.
Chromatin was, then immunoprecipitated by Snail antibody (#
ab85931 Abcam, UK) and an IgG control (Sigma).
Immunoprecipitated chromatin was reverse cross linked by heat-
ing at 60 C overnight with 200 mM NaCl. Denatured protein was
precipitated by phenol chloroform (25:1) and DNA fragments were
eluted by PCR puriﬁcation kit (Biobasic, Canada). Presence of
Cripto-1 promoter fragments was analyzed with Cripto-1 gene
promoter speciﬁc primers F: 50-CCGAAAAGAGTACCTCTGATC-30, R:
50-CTTTCGGCCTTGGACGTTTTGACC-30. Further, ampliﬁcation-
speciﬁcity was conﬁrmed by nucleotide sequencing of the DNA.
3. Results
3.1. Identiﬁcation of putative Snail-binding elements on Cripto-1
promoter
Cripto-1 is an oncofetal protein vital for embryonic develop-
ment. In humans the gene is located at the chromosomal locus
3p21.31 [26]. It is known to stabilize the transcription factor
Snail, which in turn promotes cell migration by down regulating
genes involved in cell proliferation and ceasing cell cycle. Though
the Cripto-1 stabilized Snail acts antagonistic to Cripto-1 in regu-
lating cell proliferation, the impact of Snail on Cripto-1 expression
is not yet elucidated. In order to understand this regulatory phe-
nomenon, Cripto-1 promoter sequence was analyzed for the pres-
ence of Snail-binding elements (SBE: 50-CANNTG-30) by
transcription factor binding analysis tool Consite (http://con-
site.genereg.net). This prediction revealed presence of the four
putative Snail-binding sites (SBE1 from 294 to 288; SBE2 from
234 to 228; SBE3 from 1429 to 1423 and SBE4 from 1945
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scription start site) (Fig. 1A).
3.2. Snail represses Cripto-1 promoter activity
Luciferase assays were performed to understand the impact of
Snail on the expression of Cripto-1, as described earlier [27].
Brieﬂy, Cripto-1 promoter (2489 to +8 bp) was cloned into
pGL4.20 vector that bears a luciferase gene (Fig. 1A). Upon expres-
sion of the putative transcription-factor, the luciferase expression
is read-out and is representative of the promoter-strength. Co-
transfection of Snail with Cripto-1 promoter drastically reduces
the luciferase activity in a dose-dependent manner, indicating that
Snail negatively regulates Cripto-1 promoter (Fig. 1B). The estima-
tion of efﬁciency of transfection is normalized by a control trans-
fection of b-gal and normalized by a colorimetric method
(Fig. 1B). The dose dependent increase in the Snail transfection is
additionally conﬁrmed by western blot (Fig. 1C).
3.3. Snail causes repression of Cripto-1 expression
Snail-mediated repression of Cripto-1 promoter was further
conﬁrmed by estimating the changes in relative mRNA levels of
Cripto-1 by transfecting Snail in increasing amounts, in two cancer+1 TSS
Cripto-1 Promoter
Exon1 Exon2
Cripto-
+1 TSS
5'
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Fig. 1. Cripto-1 promoter activity in cells over expressing Snail. (A) Schematic overview re
into 6 exons along the short arm of chromosome 3. The cloning of the Cripto-1 promoter r
to ascertain the strength of the promoter and its regulation by Snail. (B) Construct expres
reporter constructs harboring the Cripto-1 promoter. Empty reporter vector is used as v
construct is utilized to ensure equal transfection efﬁciency. The relative luciferase activit
in triplicates and repeated at least 3 times. ** Indicates P-value < 0.05 compared to contro
the same batch of transfected cells, to conﬁrm increasing Snail levels upon increasing am
actin. The blot is representative of 3 experiments (n = 3).cell lines. MCF-7 is a Snail deﬁcient cell line [28], whereas IMR-32
expresses Snail endogenously (Fig. 2A). Though the endogenous
Cripto-1 mRNA levels in MCF-7 and IMR-32 do not vary much
(Data not shown), the relative levels of Cripto-1 mRNA are
decreased in both MCF-7 and IMR-32 with increase in the amount
of recombinant Snail transfected (Fig. 2C). Snail mediated repres-
sion is also conﬁrmed by shRNA-mediated depletion of Snail.
Snail shRNA causes speciﬁc reduction of Snail protein in IMR-32
and recovery of Cripto-1 mRNA levels to baseline, whereas the
shRNA against Snail elicited no signiﬁcant effect on MCF-7 cells,
as expected (Fig. 2B and D).
3.4. In vitro analysis of direct interaction of Snail and Cripto-1
promoter
To monitor the physical interaction between Snail and Cripto-1
promoter, we selected the third putative Snail-biding site (with
maximum cut off value) on Cripto-1 promoter. Incubation of 33
base pair oligos representing this site with nuclear protein extracts
(NPE) of IMR-32 cells lead to a shift in migration and (the level of
migration as estimated by the intensity of the band) is dependent
on the amount of NPE used (Fig. 3B, lanes 2 and 3). Incubation of
control or mutant oligos with the NPE failed to elicit any difference
in migration (Fig. 3B, lanes 1, 5 and 6). Similarly, incubation of NPEExon3 Exon4 Exon5 Exon6
1 genic-region
3'
3'
PGL4.20-
Cripto-1 
Firefly Luciferase Gene
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β-actin
Amount of Snail transfected in ng 
     0              200          400           800 
C 
presenting the intron–exon organization of Cripto-1. The Cripto-1 gene is organized
egion upstream of the luciferase gene is schematically displayed. The clone was used
sing Snail was transfected at indicated increasing concentrations in cells along with
ector control, pCDNA3 is used as control for Snail transfection and b-Galactosidase
y is plotted as a function of increasing Snail expression. Experiments are carried out
l cells. (C) Over-expressing Snail levels are measured by Western blot analysis from
ounts of transfected Snail gene containing vector. Equal loading is conﬁrmed by b-
AC
D
B
Fig. 2. Alteration of Cripto-1 expression in response to Snail. (A) Analysis of endogenous Snail expression in the human breast cancer cell line MCF-7 and the human
neuroblastoma cell line-IMR-32. (B) MCF-7 and IMR-32 cells were transfected with increasing amounts of Snail expressing construct and RT-qPCR was performed to measure
the levels of Cripto-1 mRNA. (C) shRNA construct or a control vector was transfected in MCF-7 and IMR-32 cells to silence Snail and the change in the levels of Cripto-1 mRNA
levels was assayed by RT-qPCR. Experiments were carried out in triplicates and repeated at least 3 times. ** Indicates P-value < 0.05 compared to control cells. (D) Snail levels
are measured by Western blotting from the same batch of transfected cells to conﬁrm Snail-expression as well as knock-down in Snail transfected, control shRNA construct
and shRNA-Snail constructs. Equal loading is conﬁrmed by b-actin. The blot is representative of 3 experiments (n = 3).
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the intensity of migrated oligos band but not by control IgG, indi-
cating that this migration is speciﬁc to the Snail protein interaction
with its binding site on the oligos (Fig. 3A and C). Further, we con-
ﬁrmed the speciﬁcity of interaction between Snail and Cripto-1
promoter using MCF-7 NPE as a negative control (Fig. 3D). To fur-
ther validate that the interaction of Snail with the Cripto-1 pro-
moter is speciﬁc to IMR-32 cells, we perform EMSA with the NPE
of MCF-7 and IMR-32 cells. We observe that there is no interaction
of the oligonucleotides with the MCF-7 NPE at various NPE
amounts whereas in IMR-32 cells there was a clear shift, demon-
strating speciﬁcity in interaction.
3.5. In vivo analysis of direct Snail and Cripto-1 promoter interaction
In vivo interaction of Snail with Cripto-1 promoter is demon-
strated by the chromatin immunoprecipitation (ChIP) assay.
Brieﬂy, DNA bound proteins in cells were cross-linked and fol-
lowed up by antibody mediated precipitation, using a transcription
factor speciﬁc antibody or a control IgG antibody. The relative
abundance of the transcription factor-bound promoter fragment
is then assayed in the immuno-precipitate using PCR, where pri-
mers are designed to span the predicted transcription factor bind-
ing site. If the transcription factor is indeed bound to the DNA, itwill be ampliﬁed in the PCR reaction. In our study, we found that
the predicted SBEs on the Cripto-1 promoter were ampliﬁed only
when Snail-speciﬁc antibody is used for pull down, demonstrating
the speciﬁcity of Snail binding to Cripto-1 promoter. Equal loading
is conﬁrmed using total input DNA (Fig. 4).
3.6. Snail mediated repression of Cripto-1 alters EMT and cell-cycle
related gene expression
Based on the observation that Snail causes direct repression of
Cripto-1 activity, we ascertained whether this repression also
inﬂuences the EMT markers as well as the changes to the cell cycle
by expressing Snail both exogenously in IMR-32 cells (Fig. 5A) and
ectopically in MCF-7 cells (Fig. 5B). We observe that in both cases
cells begin to undergo EMT transition upon expression of Snail due
to a reduction in the levels of E-cadherin and increased levels of
Vimentin. Interestingly, Snail strongly represses the levels of
Cyclin D1 levels in agreement with its role in suppressing the
cell-cycle but promoting EMT, while its expression correlates with
the induction of p21 in agreement with the negative effect of Snail
on the cell cycle (Fig. 5A and B). The exogenous expression of
Cripto-1 collaborates with Snail and strongly represses E-cadherin.
Interestingly Vimentin appearing late during EMT is affected in
snail over-expressing cells only.
IMR-32MCF-7 
1            2           3 1            2           3 
Amount of NPE used 
in ug
Shift
MCF-7 
NPE
3  
IMR-32
NPE
3
Free oligos
Oligos
control
A
B C
D
Fig. 3. Interaction of Cripto-1 promoter region with endogenous Snail in vitro in IMR-32 cells nuclear lysates. Total nuclear protein extract (NPE) was isolated from IMR-32
cells that express Snail endogenously. (A) Cripto-1 promoter region spanning the Snail binding element was synthesized, along with ±15 bp as a duplex and annealed (for
measuring shift). (B) Lane 1 represents Oligos control. Lane 2 represents Oligos with 2 lg NPE. Lane 3 represents oligos with 4 lg NPE. Lane 4 represents NPE control. Lane 5
represent mutant oligos incubated with 4 lg NPE. Lane 6 represents free mutant oligos. (C) In order to conﬁrm the speciﬁcity of Snail mediated shift, NPE was incubated with
Snail antibody (Abcam) and a control IgG before performing EMSA. Lane 1 represents Oligos control. Lane 2 represents Oligos with 4 lg NPE. Lane 3 represents oligos with 4 lg
NPE and 2 lg IgG antibody. Lane 4 represents oligos with 4 lg NPE and 1 lg Snail antibody. Lane 5 represents oligos with 4 lg NPE and 2 lg Snail antibody. (D) Total NPE was
isolated from IMR-32 cells and MCF-7 cells. Lane 1 represents NPE of MCF7 Lane 2, 3 and 4 represent increasing concentration of MCF-7 NPE. Lane 5 represents NPE of IMR-32.
Lane 6, 7 and 8 represent increasing concentration of IMR-32 NPE. Lane 9 represents oligo control.
IMR-32
MCF-7
Input ChIP 
IgG Snail IgG Snail
250- 
200
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250- 
200
150
Fig. 4. Interaction of Snail with the Cripto-1 promoter in vivo. Chromatin immunoprecipitation (ChIP) was performed in IMR-32 cells for the putative Snail-binding sites. The
cells expressing endogenous Snail were cross linked using formaldehyde followed by shearing and immunoprecipitation using a Snail speciﬁc or IgG control antibody. The
resulting chromatin was reverse-cross linked and ampliﬁed using the primers ﬂanking the two putative Snail-binding sites. Equal loading was conﬁrmed by the ampliﬁcation
of input chromatin. The resulting blot is representative of 3 experiments (n = 3).
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Fig. 5. Snail and Cripto-1 exogenous expression causes alteration in EMT and cell-cycle markers. Levels of EMT markers E-cadherin and Vimentin and cell cycle markers
Cyclin D1 and p21 are assayed by western blotting upon exogenous expression of the constructs, as indicated, for (A) IMR-32 and (B) MCF-7 cells. Equal lading is conﬁrmed by
b-Actin. The blot is representative of 3 experiments (n = 3).
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Snail is an important, if not the only converging point for
coordinating the temporal regulation of genes that help cells egress
from the epithelial lineage [15]. In the current work, we identify
Cripto-1 promoter as the speciﬁc transcriptional target of Snail
and report a repressive mode of regulation that might facilitate
the entry of cells into mesenchymal lineage. A bioinformatics
based screen for putative transcription factor binding sites on the
Cripto-1 promoter led to the identiﬁcation of Snail as a probable
transcription factor. We followed this by reporter assays that
demonstrate reduced Cripto-1 promoter activity upon increasing
Snail transfection. Further, we validate the reduced promoter
activity by quantifying the mRNA levels and observe a similar
trend of reduced Cripto-1 mRNA levels with increasing Snail.
Subsequent to our ﬁnding that Snail represses Cripto-1 promoter
activity and expression, we ascertained whether the observed
reduction in Cripto-1 transcript (and promoter activity with
increasing Snail levels) is a result of direct transcriptional interac-
tion. We performed promoter binding studies in vivo and also
in vitro. We observed that reconstituted interaction of Snail con-
taining NPE of IMR-32 cells and oligonucleotides of Cripto-1 pro-
moter sequence (containing SBE) leads to a speciﬁc interaction as
demonstrated by our EMSA data. In addition, ChIP analysis demon-
strated that the promoter binding by Snail also happens in cells
(in vivo). Taken together, the standard assays for transcription fac-
tor with its cognate site on the DNA interaction demonstrate a
direct interaction of Snail with Cripto-1 promoter and functional
assays suggest a repressive mode of regulation. We demonstrate
that the repression of Cripto-1 by Snail causes changes in the early
markers of EMT by suppressing epithelial markers and promoting
mesenchymal markers, as well as alterations in cell-cycle progres-
sion through suppression of cyclin D1 and increased p21 expres-
sion. Importantly, the interaction is speciﬁc to IMR-32 cells that
express endogenous Snail but is recapitulated by ectopic expres-
sion of Snail in MCF-7 cells.
Indirect evidences have previously demonstrated that interac-
tions between Snail and Cripto-1 are required for the positiveregulation of EMT [11]. Therefore, our observation of Snail-
mediated Cripto-1 repression is physiologically insightful.
Limited studies on the interaction of Snail and Cripto-1 in past
reports have demonstrated that Cripto-1 facilitates the stabiliza-
tion of Snail at the protein level, which is in agreement to their col-
laborative roles in promoting EMT [29].
Our novel observation of a repressive mode of regulation might
relate to the numerous instances where Cripto-1 and Snail play
antagonistic roles and therefore, Snail-mediated repression of
Cripto-1 assumes special importance. For instance, it is now well
established that Cripto-1 provides growth-advantage to cells by
participating in key pathways involved in growth and self-renewal
[11]. Further, Strizzi et al. have reported that Cripto-1 is associated
with increased cell-cycling activities through Cyclin D1 activation
in mammary tumors [29]. In contrast, Snail is involved in arresting
the cell-cycle in various contexts, including breast cancers [17,21].
In addition, Cripto-1 provides cells with increased self-renewal
potential and maintenance of stemness, whereas Snail is actively
involved in the differentiation of cells [5,30–32]. Taken together,
Snail and Cripto-1 are also involved in antagonistic processes of
growth and differentiation. Our data provides a molecular basis
for these observations – Snail-mediated repression of Cripto-1
expression.
Based on previous reports, we suspect that Cripto-1 repression
by Snail is context speciﬁc and highlight that transcriptional
activators directly upregulate Cripto-1 during EMT transitions
[11]. In this regard, we observed that the mRNA levels of
Cripto-1 did not vary signiﬁcantly in IMR-32 and MCF-7 cells
despite varying Snail expression. It has been reported that
Cripto-1 is quite dynamically regulated in IMR-32 cells, as neural
transcription factors like N-myc promotes expression of TCF3
which inturn promotes Cripto-1 expression. This might restore
Cripto-1 expression even in the presence of Snail [11,33]. Also sig-
naling pathways like anaplastic lymphoma kinase (ALK)/b-catenin/
Cripto-1 speciﬁc to IMR-32 cells might upregulate Cripto-1 in MCF-
7 [11,34,35]. In addition complex regulatory network of transcrip-
tion factors may cause differential Cripto-1 expression. For
example, Msx2, a homeobox domain containing transcription
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Cripto-1 expression [36]. Also, a short form of Cripto-1 (lacking
the ﬁrst two exons) is found to be upregulated by Wnt pathway
owing to the binding of the beta-Catenin/TCF/LEF complex to the
cis-elements on the Cripto-1 promoter [37]. Also, Cripto-1 inturn
induce Snail expression. It has recently been found that a Snail-
related transcription factor, Twist, is associated with a signiﬁcant
fraction of genes that Snail binds [38]. In contrast to the repressive
role of Snail, the binding of Twist promotes the transcription of the
target gene [39]. Therefore, Cripto-1 could be an interesting target
gene that is co-regulated by Snail and Twist, along with other
transcription factors promoting EMT. A deﬁnitive knowledge of
the upstream regulators of Cripto-1 that promote EMT is now
beginning to emerge.
Past studies have also demonstrated the involvement of other
transcription factors in activating Cripto-1 expression that are
related to EMT in less direct manner [11]. Some of these include
those proteins that are more directly associated with the overlap-
ping functions of controlling self-renewal as well as motility. For
example, the hypoxia-inducible factor 1a (Hif1a) was reported to
activate Cripto-1 expression and is also known to promote EMT
[22]. In addition, Cripto-1 promoter is bound by Nanog and is also
predicted to bind to Oct3/4, thereby correlating with the self-
renewal and pluripotency-potential of Cripto-1 [11].
Therefore, while a number of positive-regulators of Cripto-1 are
already described in over-lapping contexts of promoting EMT and
potential in providing stemness, the simultaneous retention of
the EMT function and oncogenic role in maintenance of undiffer-
entiated state was unknown. Our ﬁnding of a novel, negative
regulator of Cripto-1 expression, therefore, provides an under-
standing of how Cripto-1 expression may also be negatively modu-
lated for successful development and oncogenesis.Acknowledgements
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